Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
New COVID ‘FLiRT’ variants show virus isn’t going away
The Hill via Yahoo News· 3 days agoThe most recent dominant variants of SARS-CoV-2, the virus that causes COVID-19, are part of a group...
SARS-CoV-2 vaccine does not increase new-onset seizure risk
Medical Xpress· 2 weeks agoThere is no risk for new-onset seizure incidence for individuals receiving a severe acute...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 12 hours agoA spokesperson for the CDC tells Nexstar that the agency is “working to better understand [KP.2 and...
Transfected SARS-CoV-2 spike DNA suppresses cancer cell response to chemotherapy
Medical Xpress· 5 days agoSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer ...
Doctors Warn About 2 New COVID Variants—What to Know About ‘FLiRT’ Strains
Prevention· 6 days agoFLiRT COVID-19 variants, KP.1.1 and KP.2, are spreading in the U.S. The current COVID vaccine may...
COVID-19 Proteins Can Hang Around In The Blood For Up To 14 Months After Infection
IFLScience· 2 weeks agoThe idea that SARS-CoV-2, the virus behind COVID-19, may be able to persist in the body long after...
A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential...
Medical Xpress· 2 weeks agoPeople who are infected with SARS-CoV-2, the virus that causes COVID-19, currently have two options...
ESCMID Presenters Make Case for Saliva Samples in Molecular Infectious Disease Testing
GenomeWeb News· 2 weeks agoSaliva is a promising sample type for molecular diagnostic testing in infectious diseases beyond ...
Scientists tried to give people COVID — and failed
Nature· 2 weeks agoResearchers deliberately infect participants with SARS-CoV-2 in ‘challenge’ trials — but high levels of immunity complicate efforts to test vaccines and...